Early Precut in Difficult Biliary Cannulation

NCT ID: NCT02596646

Last Updated: 2015-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

375 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates whether an early precut strategy in cases of difficult biliary cannulation could reduce the incidence of PEP compared with that after prolonged cannulation attempts. Secondary aims are to compare the success of biliary cannulation and complications rates of the two techniques.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this prospective multicenter randomized clinical trial the investigators assign patients referred for therapeutic biliary ERCP and difficult biliary cannulation (unsuccessful cannulation after 5 minutes) to early precut (group A) or repeated papillary cannulation attempts followed, in case of failure, by late precut (group B). Group A patients undergo precut immediately after randomization ("early precut"), while for group B cannulation attempts are continued for another 10 minutes, after which a precut is done if these fail or there are three unintended additional passages of the guide-wire into the MPD ("delayed precut").

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Common Bile Duct Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Early Precut

Group Type ACTIVE_COMPARATOR

Early Precut

Intervention Type PROCEDURE

Early precut was performed during ERCP with difficult biliary cannulation

Group B

Prolonged cannulation attempts

Group Type ACTIVE_COMPARATOR

Prolonged cannulation attempts

Intervention Type PROCEDURE

Prolonged cannulation attempts was performed during ERCP with difficult biliary cannulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early Precut

Early precut was performed during ERCP with difficult biliary cannulation

Intervention Type PROCEDURE

Prolonged cannulation attempts

Prolonged cannulation attempts was performed during ERCP with difficult biliary cannulation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 to 85 years of age who were scheduled to undergo therapeutic biliary ERCP.

Exclusion Criteria

* active cholangitis or pancreatitis
* chronic pancreatitis,
* previous sphincterotomy,
* prior gastric surgery,
* coagulopathy,
* severe comorbidity (need for tracheal intubation)
* patients who refused or were unable to give informed consent.
* patients with successful CBD cannulation within 5 minutes of standard attempts and fewer than three passages of the guidewire into the main pancreatic duct (MPD) (arbitrarily defined as "easy CBD cannulation"),
* detection of ampulloma or peri-papillary diverticula during ERCP.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

San Giuseppe Moscati Hospital

OTHER

Sponsor Role collaborator

Istituti Ospitalieri di Cremona

OTHER

Sponsor Role collaborator

Valduce Hospital

OTHER

Sponsor Role collaborator

Papa Giovanni XXIII Hospital

OTHER

Sponsor Role collaborator

Cardarelli Hospital

OTHER

Sponsor Role collaborator

Azienda Ospedaliera Universitaria Senese

OTHER

Sponsor Role collaborator

Maresca Hospital

OTHER

Sponsor Role collaborator

Università Vita-Salute San Raffaele

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Testoni Pier Alberto

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pier Alberto Testoni, Professor

Role: PRINCIPAL_INVESTIGATOR

San Raffaele Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

San Raffaele Hospital

Milan, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRECUT PRECOCE/01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gallbladder Stenting in FC-SEMS
NCT06820541 NOT_YET_RECRUITING NA